Future studies to identify other binding partners at cell-cell junctions and functional studies of the role of CLCA2 metalloprotease activity on the organization of lateral junctions may reveal new tumor suppressive pathways that can be exploited in cancer prevention or therapy. The gene discussed is CLCA2; the disease is cancer.